Array 10-Q2011 Q1 Quarterly report

Filed: 9 Nov 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: AKT, BRAF, colorectal, Debtincluded, digit, double, failed, incurrence, influenced, inhibition, inNote, invented, kinase, mutant, oral, Plansto, Presentationunder, publicly, reimburse, reimbursement, Revenuefor, Revenueto, Securitiesfor, Securitiesin, SeeNote, selumetinib, smaller, transitioning, Trk, tyrosine

Removed: academic, accelerating, activity, acute, adequate, advancing, aggregated, allergy, alternative, AML, amounting, announced, assure, attain, attract, attracting, attractive, averaged, bankruptcy, caliber, charge, Chk, cohesive, collaborated, collaborative, commit, compete, conserve, considerably, Conway, costly, Counsel, David, dependent, deteriorate, determination, devoted, direction, discounted, domestic, downturn, Dr, dual, easily, Eli, employment, environment, evaluating, expanding, expended, exposed, federal, focusing, goal, guaranty, hire, inaccurate, issuing, John, Kevin, Koch, KSP, lab, Lehman, leukemia, Lilly, literature, manufacture, maximize, MDS, Michael, MM, Moore, motivate, motivating, myelodysplastic, myeloid, myeloma, obtained, optimizing, personal, precisely, President, primary, progressing, pronouncement, prospectively, public, qualified, receiving, recent, recently, receptor, reconciliation, recruit, renewing, restructuring, retain, retaining, Robert, rollforward, securing, seek, shifting, skilled, Snitman, stable, standard, syndrome, terminable, unavailability, vested, Vice, widen, workforce

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Array similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Robert E. Conway, Chief Executive Officer of Array BioPharma Inc. (the “Company”), and R. Michael Carruthers, Chief Financial Officer of the Company, do each hereby certify that, to the best of his knowledge and except as corrected or supplemented in a subsequent periodic report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the date hereof:

	(a)		the Quarterly Report on Form 10-Q of the Company for the three-month period ended September 30, 2010, filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

	(b)		the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The undersigned have executed this Certificate as of the 8th day of November 2010.



	/s/ Robert E. Conway
	Robert E. Conway
	Chief Executive Officer


	/s/ R. Michael Carruthers
	R. Michael Carruthers
	Chief Financial Officer